Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Anticancer Research
|
September 1, 1993
Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo
T Watanabe, S Fuchimoto, H Iwagaki, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
February 24, 2005
[Successful resection of left ventricular myxoma in a toddler; report of a case]
Daisuke Heima, S Nemoto, T Ikeda, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
September 16, 2004
[Oral sildenafil citrate as an effective alternate in the treatment of postoperative pulmonary hypertensive crisis after congenital heart surgery]
Shintaro Nemoto, E Umehara, T Ikeda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2013
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors
N Yamamoto, H Murakami, T Nishina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2003
A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting
I Hyodo, T Nishina, T Moriwaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2009
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
W Koizumi, N Boku, K Yamaguchi, et al.
British Journal of Cancer
|
January 31, 2008
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
J Matsubara, T Nishina, Y Yamada, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 12, 2014
Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study
T Moriwaki, T Kajiwara, T Matsumoto, et al.
British Journal of Cancer
|
September 19, 2013
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
W Koizumi, K Yamaguchi, H Hosaka, et al.
ESMO Open
|
November 28, 2023
Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study
Y Narita, T Matsushima, Y Sakamoto, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Anticancer Research
|
September 1, 1993
Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo
T Watanabe, S Fuchimoto, H Iwagaki, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
February 24, 2005
[Successful resection of left ventricular myxoma in a toddler; report of a case]
Daisuke Heima, S Nemoto, T Ikeda, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
September 16, 2004
[Oral sildenafil citrate as an effective alternate in the treatment of postoperative pulmonary hypertensive crisis after congenital heart surgery]
Shintaro Nemoto, E Umehara, T Ikeda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2013
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors
N Yamamoto, H Murakami, T Nishina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 15, 2003
A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting
I Hyodo, T Nishina, T Moriwaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2009
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
W Koizumi, N Boku, K Yamaguchi, et al.
British Journal of Cancer
|
January 31, 2008
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
J Matsubara, T Nishina, Y Yamada, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 12, 2014
Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study
T Moriwaki, T Kajiwara, T Matsumoto, et al.
British Journal of Cancer
|
September 19, 2013
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
W Koizumi, K Yamaguchi, H Hosaka, et al.
ESMO Open
|
November 28, 2023
Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study
Y Narita, T Matsushima, Y Sakamoto, et al.
Page
of 9